Showing 2641-2650 of 18630 results for "".
Unveiling the Role of Obesity in MASLD Progression
https://reachmd.com/programs/clinicians-roundtable/obesity-masld-progression/39656/Advancing Care: Clinical Innovations on the Horizon
https://mededonthego.com/programs/cme/advancing-care-clinical-innovations-on-the-horizon/35881/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
https://reachmd.com/programs/cme/chairperson-perspective-acromegaly-care-individualized-diagnosis-and-management-strategies/33027/Join us to discover the current recommendations and scientific data on the diagnosis and therapeutic management of acromegaly.Examining Airway Tolerability of a Climate Conscious Inhaler
https://reachmd.com/programs/clinicians-roundtable/airway-tolerability-climate-conscious-inhaler/54178/Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
https://reachmd.com/programs/eye-on-ocular-health/anti-vegf-use-in-retinal-vein-occlusion-insights-from-a-real-world-cohort/37662/Integrating Lipoprotein(a) Into Cardiovascular Risk Assessment
https://reachmd.com/programs/heart-matters/Integrating-Lipoprotein-a-Into-Cardiovascular-Risk-Assessment/37595/Advances in the Management of Moderate-to-Severe Atopic Dermatitis
https://reachmd.com/programs/cme/advances-in-the-management-of-moderate-to-severe-atopic-dermatitis/10967/This multidisciplinary faculty panel and a patient deliberate over challenging topics in moderate-to-severe atopic dermatitis.Early Referral in PMR Management and the Impact on Outcomes
https://reachmd.com/programs/medical-industry-feature/early-referral-in-pmr-management-and-the-impact-on-outcomes/32971/TBDBreaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
https://reachmd.com/programs/cme/breaking-new-ground-acoramidis-reduces-af-events-in-attr-cm-patients-from-esc-heart-failure-2025/36590/Review data from ESC Heart Failure 2025 on acoramidis and its association with reduced atrial fibrillation and improved outcomes in ATTR-CM.Silent Brain Damage in ATTR-CM: Exploring Neurological Impacts
https://reachmd.com/programs/spotlight-attr-cm/silent-brain-damage-in-attr-cm-exploring-neurological-impacts/32418/ATTR-CM patients can experience brain damage with no apparent symptoms. Read about a recent study on this concerning phenomenon.